drugset / Trial / NCT01127100
Gabapentin Versus Transdermal Fentanyl Matrix for Chronic Neuropathic Pain
Phase 4
Completed
108 enrolled
Seoul National University Hospital
Asan Medical Center · collabChonnam National University Hospital · collabChung-Ang University Hospital · collabDankook University · collabInje University · collabSeoul National University Bundang Hospital · collab
RandomizedParallel-groupSingle-blindTreatment
Summary
Gabapentin is a first line medication and fentanyl is second line medication in neuropathic pain. But, there is no head to head study on the efficacy of those medication in neuropathic pain. The hypothesis of this study is that the efficacy of the transdermal fentanyl matrix is not inferior to the gabapentin in neuropathic pain.
Timeline
- Start
- 2010-05
- Primary completion
- 2011-11
- Completion
- 2011-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fentanyl | Other / unclassified | 100 ug | Other |
| Subject | Gabapentin | Small molecule | 2400 mg | — |